Amarin Corporation plc ADR (AMRN)

Profile

https://www.amarincorp.com

Amarin Corporation plc ADR is a biopharmaceutical company focused on cardiovascular health. Its commercial activities center on developing and marketing therapies for patients with elevated triglycerides and other cardiovascular risk factors, with Vascepa as its primary marketed product. The company serves healthcare providers and patients across the United States, Europe, and other international markets, using a model built around prescription medicines and physician-driven adoption. Amarin Corporation plc ADR operates in the pharmaceutical sector with an emphasis on lipid science and omega-3-based therapy, positioning its products within the broader treatment landscape for cardiovascular disease management. Headquartered in Dublin, Ireland, the company remains concentrated on commercializing approved therapies and supporting their use in routine clinical care.